Trial intelligence / Profile preview

Radiofrequency vs Doxycycline in Papulopustular Rosacea

NCT02204254Completed

Sponsor
Centre Hospitalier Universitaire de Nice
Start
Mar 2014
Primary completion
Apr 2018
Countries
1
01

Overview

Randomised, open-label trial in papulopustular rosacea, sponsored by Centre Hospitalier Universitaire de Nice. Primary endpoint: Physician Global Assessment 0 or 1 at 24 weeks. Started Mar 2014; status: completed.

02

Conditions

papulopustular rosacea

Beyond the preview

Go deeper on NCT02204254.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02204254.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call